IN2014DN09789A - - Google Patents
Info
- Publication number
- IN2014DN09789A IN2014DN09789A IN9789DEN2014A IN2014DN09789A IN 2014DN09789 A IN2014DN09789 A IN 2014DN09789A IN 9789DEN2014 A IN9789DEN2014 A IN 9789DEN2014A IN 2014DN09789 A IN2014DN09789 A IN 2014DN09789A
- Authority
- IN
- India
- Prior art keywords
- lactic acid
- oligomeric lactic
- trimer
- integer
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/225—Polycarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/67—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
- C07C69/675—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids of saturated hydroxy-carboxylic acids
- C07C69/68—Lactic acid esters
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Emergency Medicine (AREA)
- Inorganic Chemistry (AREA)
- Endocrinology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Polyesters Or Polycarbonates (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA201270431 | 2012-07-16 | ||
| PCT/EP2013/064265 WO2014012805A1 (en) | 2012-07-16 | 2013-07-05 | Pharmaceutical compositions containing oligomeric lactic acid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014DN09789A true IN2014DN09789A (OSRAM) | 2015-07-31 |
Family
ID=48793207
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN9789DEN2014 IN2014DN09789A (OSRAM) | 2012-07-16 | 2014-11-19 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US9370502B2 (OSRAM) |
| EP (1) | EP2872117B1 (OSRAM) |
| JP (1) | JP6149109B2 (OSRAM) |
| KR (1) | KR102089117B1 (OSRAM) |
| CN (1) | CN104470498B (OSRAM) |
| AU (1) | AU2013292179B2 (OSRAM) |
| BR (1) | BR112015001006B1 (OSRAM) |
| CA (1) | CA2875784C (OSRAM) |
| DK (1) | DK2872117T3 (OSRAM) |
| ES (1) | ES2652251T3 (OSRAM) |
| IN (1) | IN2014DN09789A (OSRAM) |
| MX (1) | MX356750B (OSRAM) |
| NO (1) | NO2872117T3 (OSRAM) |
| PL (1) | PL2872117T3 (OSRAM) |
| RU (1) | RU2627470C2 (OSRAM) |
| WO (1) | WO2014012805A1 (OSRAM) |
| ZA (1) | ZA201409039B (OSRAM) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2709464C2 (ru) | 2015-09-29 | 2019-12-18 | Кимберли-Кларк Ворлдвайд, Инк. | Синергическая композиция для сохранения здорового баланса микрофлоры |
| CN105327405B (zh) * | 2015-10-23 | 2019-01-29 | 华南理工大学 | 用于治疗宫颈炎的载药支架及其制备方法 |
| US12029748B2 (en) | 2017-02-28 | 2024-07-09 | Kimberly-Clark Worldwide, Inc. | Synergistic composition for maintenance of healthy balance of microflora |
| CN109288793B (zh) * | 2018-07-27 | 2021-07-16 | 江苏中天药业有限公司 | 一种用于阴道pH环境调节的喷雾剂及其制备方法 |
| EP4486310A1 (en) | 2022-03-01 | 2025-01-08 | Combe International, LLC | Process for preparation of compositions of oligomers of lactic acid |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6552024B1 (en) * | 1999-01-21 | 2003-04-22 | Lavipharm Laboratories Inc. | Compositions and methods for mucosal delivery |
| AU2002325614A1 (en) * | 2001-08-16 | 2003-03-03 | Pharmacon-Forschung Und Beratung Gmbh | Compounds containing lactic acid elements, method for the production and use thereof as pharmaceutically active substances |
| SE528337C2 (sv) * | 2004-06-23 | 2006-10-24 | Nestor Medical Ab | Sammansättning innefattande mjölksyra och laktoferrin, eller ett peptidfragment därav, och användning av denna sammansättning för behandling av tillstånd i urogenitalsystemet |
| RU2308951C2 (ru) * | 2005-08-18 | 2007-10-27 | Виктор Игоревич Высоков | Комплексный способ профилактики вагинальных дисбактериозов (варианты) |
| WO2008062446A2 (en) * | 2006-09-14 | 2008-05-29 | Alembic Limited | An extended release composition of levetiracetam, which exhibits no adverse food effect |
| HRP20140559T1 (hr) * | 2007-03-30 | 2014-08-01 | Laccure Ab | Uporaba oligomera mlijeäśne kiseline u lijeäśenju ginekoloških infekcija |
-
2013
- 2013-07-05 PL PL13737191T patent/PL2872117T3/pl unknown
- 2013-07-05 US US14/414,745 patent/US9370502B2/en active Active
- 2013-07-05 EP EP13737191.0A patent/EP2872117B1/en active Active
- 2013-07-05 KR KR1020157001129A patent/KR102089117B1/ko active Active
- 2013-07-05 CN CN201380037782.XA patent/CN104470498B/zh active Active
- 2013-07-05 ES ES13737191.0T patent/ES2652251T3/es active Active
- 2013-07-05 WO PCT/EP2013/064265 patent/WO2014012805A1/en not_active Ceased
- 2013-07-05 CA CA2875784A patent/CA2875784C/en active Active
- 2013-07-05 BR BR112015001006-7A patent/BR112015001006B1/pt active IP Right Grant
- 2013-07-05 NO NO13737191A patent/NO2872117T3/no unknown
- 2013-07-05 RU RU2015104974A patent/RU2627470C2/ru active
- 2013-07-05 JP JP2015522035A patent/JP6149109B2/ja not_active Expired - Fee Related
- 2013-07-05 MX MX2015000564A patent/MX356750B/es active IP Right Grant
- 2013-07-05 DK DK13737191.0T patent/DK2872117T3/en active
- 2013-07-05 AU AU2013292179A patent/AU2013292179B2/en active Active
-
2014
- 2014-11-19 IN IN9789DEN2014 patent/IN2014DN09789A/en unknown
- 2014-12-09 ZA ZA2014/09039A patent/ZA201409039B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL2872117T3 (pl) | 2018-02-28 |
| JP6149109B2 (ja) | 2017-06-14 |
| ES2652251T3 (es) | 2018-02-01 |
| US20150164848A1 (en) | 2015-06-18 |
| CA2875784A1 (en) | 2014-01-23 |
| EP2872117B1 (en) | 2017-09-27 |
| WO2014012805A1 (en) | 2014-01-23 |
| RU2627470C2 (ru) | 2017-08-08 |
| CA2875784C (en) | 2020-03-10 |
| MX356750B (es) | 2018-06-12 |
| ZA201409039B (en) | 2020-01-29 |
| CN104470498A (zh) | 2015-03-25 |
| KR20150036091A (ko) | 2015-04-07 |
| JP2015526413A (ja) | 2015-09-10 |
| DK2872117T3 (en) | 2018-01-08 |
| BR112015001006A2 (pt) | 2017-06-27 |
| KR102089117B1 (ko) | 2020-04-16 |
| NO2872117T3 (OSRAM) | 2018-02-24 |
| BR112015001006B1 (pt) | 2022-05-17 |
| CN104470498B (zh) | 2017-08-08 |
| AU2013292179B2 (en) | 2017-03-30 |
| MX2015000564A (es) | 2015-04-10 |
| US9370502B2 (en) | 2016-06-21 |
| WO2014012805A9 (en) | 2014-12-31 |
| EP2872117A1 (en) | 2015-05-20 |
| RU2015104974A (ru) | 2016-09-10 |
| AU2013292179A1 (en) | 2015-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2015008100A (es) | Composiciones que comprenden un compuesto de triazol. | |
| MY188960A (en) | Cyclic boronic acid ester derivatives and therapeutic uses thereof | |
| MX349827B (es) | Compuestos que contienen nitrogeno y su uso. | |
| MX346602B (es) | Compuestos beta-lactamicos sustituidos con amidina, su preparacion y uso como agentes antibacterianos. | |
| WO2011153157A3 (en) | Benzoquinolone inhibitors of vmat2 | |
| IN2014DN09346A (OSRAM) | ||
| IN2015DN00960A (OSRAM) | ||
| EA023631B9 (ru) | Замещенные 5-фтор-1h-пиразолопиридины и их применение | |
| NZ743274A (en) | Substituted tricyclic compounds as fgfr inhibitors | |
| MY160241A (en) | 5-alkynyl-pyrimidines | |
| MX2015013806A (es) | Polieteraminas a base de 1,3-dialcoholes. | |
| MX2013004759A (es) | Compuestos de oxima como agentes de elevacion de colesterol de lipoproteina de alta densidad (hdl). | |
| NZ705313A (en) | Novel 4,6-disubstituted aminopyrimidine derivatives | |
| UA114656C2 (uk) | Похідні піридину | |
| MX2014015197A (es) | Tratamiento y prevencion de la enfermedad cardiovascular y trombosis. | |
| MX2014013851A (es) | Composiciones farmaceuticas topicas que comprenden terbinafina y urea. | |
| MX363692B (es) | Bloques de construccion de 2-oxo-1, 3-dioxolano-4-carboxamida, su preparacion y uso. | |
| MX2012012993A (es) | Composiciones de tetraciclina. | |
| PH12013500694A1 (en) | Process for manufacturing dihydropteridinones and intermediates thereof | |
| SG10201900541QA (en) | Derivatives of xanthone compounds | |
| MX2014004920A (es) | Nuevos derivados de pirazina. | |
| MX342947B (es) | Tratamiento de diabetes tipo 2. | |
| PH12014500321A1 (en) | Novel substituted cyclohexane compounds | |
| MX2012010127A (es) | Derivados de aminoindanos, su preparacion y su aplicacion en terapeuticos. | |
| MX2015000564A (es) | Composiciones farmaceuticas que contienen acido lactico oligomerico. |